Management of recurrent or persistent choroidal neovascularization secondary to age-related macular degeneration A prospective, randomized, clinical study

Registry ID

EUCTR2010-021923-29

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Universitätsklinik für Augenheilkunden und Optometrie, Medizinische Universität Wien

Start date

2011-08-11

Completion date

2013-11-28

Last update

2026-08-16

Conditions

• Neovascular age-related macular degeneration

Summary

To assess the treatment effect of reduced fluence photodynamic therapy (PDT) and ranibizumab versus intravitreal dexamethasone and ranibizumab versus ranibizumab monotherapy in patients with persistent or recurrent CNV due to AMD.

Locations

• , , Austria

Related clinical trials

• Two initial aflibercept 8 mg loading doses in treatment-naive neovascular AMD

View on source registry